In the BioHarmony Drug Report Database

"Preview" Icon

Poractant alfa

Curosurf (poractant alfa) is an unknown pharmaceutical. Poractant alfa was first approved as Curosurf on 1999-11-18. It is used to treat newborn respiratory distress syndrome in the USA.

 

Trade Name

 

Curosurf
 

Common Name

 

poractant alfa
 

ChEMBL ID

 

CHEMBL1201622
 

Indication

 

newborn respiratory distress syndrome
 

Drug Class

 

Pulmonary surfactants; tachykinin (neurokinin) receptor antagonists

Image (chem structure or protein)

Poractant alfa structure rendering